PFBT
VIR icon

Parkside Financial Bank & Trust’s Vir Biotechnology VIR Stock Holding History

Parkside Financial Bank & Trust’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$359 Hold
40
– – ﹤0.01% 2604
2025
Q4 		$242 Hold
40
– – ﹤0.01% 2628
2025
Q3 		$229 Sell
40
-23
-37% -$118 ﹤0.01% 2652
2025
Q2 		$318 Sell
63
-29
-32% -$155 ﹤0.01% 2637
2025
Q1 		$597 Buy
92
+56
+156% +$498 ﹤0.01% 2288
2024
Q4 		$265 Hold
36
– – ﹤0.01% 2008
2024
Q3 		$270 Sell
36
-3
-8% -$26 ﹤0.01% 1956
2024
Q2 		$348 Hold
39
– – ﹤0.01% 1846
2024
Q1 		$396 Hold
39
– – ﹤0.01% 1801
2023
Q4 		$393 Sell
39
-682
-95% -$6.23K ﹤0.01% 1800
2023
Q3 		$6.76K Buy
721
+514
+248% +$7.33K ﹤0.01% 1257
2023
Q2 		$5.08K Sell
207
-276
-57% -$6.93K ﹤0.01% 1362
2023
Q1 		$11.2K Buy
483
+8
+2% +$205 ﹤0.01% 1063
2022
Q4 		$12K Buy
475
+142
+43% +$3.48K ﹤0.01% 1003
2022
Q3 		$6K Buy
333
+63
+23% +$1.6K ﹤0.01% 1180
2022
Q2 		$7K Buy
+270
New +$6.3K ﹤0.01% 1131

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Parkside Financial Bank & Trust's VIR Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Vir Biotechnology (VIR) position steady in Q1 2026 at 40 shares worth $359. The position accounts for ﹤0.01% of the portfolio, ranked #2604.

Parkside Financial Bank & Trust first reported a position in VIR in Q2 2022 and has held it in 16 quarters since. The position peaked at $12K in Q4 2022. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Parkside Financial Bank & Trust held 40 shares of Vir Biotechnology worth $359 as of Q1 2026.
  • Parkside Financial Bank & Trust left its Vir Biotechnology share count unchanged in Q1 2026.
  • Vir Biotechnology made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2604 holding.
  • Parkside Financial Bank & Trust first reported a position in Vir Biotechnology in Q2 2022 and has held it in 16 quarters since.
  • Parkside Financial Bank & Trust's Vir Biotechnology position peaked at $12K in Q4 2022.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.